StartupsFinSMEsabout 4 hours ago
Triveni Bio Raises $65M in Series C Funding
1 min read
Triveni Bio raised $65 million in Series C funding. The financing round supports the company's development of precision medicines for inflammatory and fibrotic diseases. The funding will advance pipeline programs toward clinical trials.
Level
Hype check
Tap to vote and see what everyone thinks.
